AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 38 filers reported holding AN2 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,599,880 | +3.4% | 99,495 | -45.3% | 0.67% | +81.0% |
| Q2 2023 | $1,546,958 | -36.7% | 181,995 | -26.5% | 0.37% | -45.3% |
| Q1 2023 | $2,442,499 | -43.0% | 247,467 | -45.0% | 0.67% | -63.5% |
| Q4 2022 | $4,288,500 | +5.8% | 450,000 | +92.9% | 1.85% | +22.7% |
| Q3 2022 | $4,055,000 | +124.3% | 233,330 | 0.0% | 1.50% | +128.6% |
| Q2 2022 | $1,808,000 | -72.3% | 233,330 | -46.2% | 0.66% | -65.2% |
| Q1 2022 | $6,530,000 | – | 433,330 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 233,330 | $4,055,000 | 1.50% |
| RA Capital Management | 3,773,517 | $65,584,000 | 1.40% |
| BVF INC/IL | 1,616,665 | $28,098,000 | 1.16% |
| Avidity Partners Management LP | 742,630 | $12,907,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 716,538 | $12,453,000 | 0.25% |
| Alyeska Investment Group, L.P. | 105,718 | $1,837,000 | 0.02% |
| Woodline Partners LP | 76,145 | $1,323,000 | 0.02% |
| Citadel Advisors | 1,336,983 | $23,237,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 5,726 | $100,000 | 0.00% |
| CITIGROUP INC | 134,545 | $2,338,000 | 0.00% |